Preventive effects of the AMPA receptor potentiator LY450108 in an LPS-induced depressive mouse model

Behav Brain Res. 2022 Apr 29:424:113813. doi: 10.1016/j.bbr.2022.113813. Epub 2022 Feb 22.

Abstract

Previous studies have demonstrated a close association between α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors (AMPARs) and depressive disorders, and activation of AMPARs may represent a promising way to treat depression. However, the effects of AMPAR potentiators on depression and the underlying mechanism have not been comprehensively clarified. We used lipopolysaccharide (LPS) to establish a depressive mouse model and an in vitro damage model of SH-SY5Y cells, and the AMPAR potentiator LY450108 was introduced to the study. We found that LY450108 alleviated LPS-induced depressive behavior and abnormal phosphorylation of hippocampal AMPARs in mice. LY450108 also alleviated LPS-induced apoptosis and decreased the viability of SH-SY5Y cells. In addition, LY450108 protected SH-SY5Y cells from LPS-induced abnormal phosphorylation of AMPARs. In conclusion, our findings suggest that LY450108 has antidepressant effects against LPS-induced neuronal damage and depression.

Keywords: AMPA receptor; Depression; LPS; LY450108.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology
  • Disease Models, Animal
  • Hippocampus / metabolism
  • Lipopolysaccharides* / pharmacology
  • Mice
  • Receptors, AMPA* / metabolism

Substances

  • Antidepressive Agents
  • Lipopolysaccharides
  • Receptors, AMPA